The Marcus Foundation makes major $25.9 million award to advance lifesaving stroke ...
A $25.9 million grant from The Marcus Foundation will fund the REACH trial, aiming to revolutionize hemorrhagic stroke treatment by investigating minimally invasive parafascicular surgery (MIPS) for deep intracerebral hemorrhage in the basal ganglia. Led by Emory University and Grady Health System, the trial seeks to improve outcomes for patients with spontaneous ICH, currently lacking a proven surgical standard of care.
Reference News
A $25.9 million grant from The Marcus Foundation will fund the REACH trial, aiming to revolutionize hemorrhagic stroke treatment by investigating minimally invasive parafascicular surgery (MIPS) for deep intracerebral hemorrhage in the basal ganglia. Led by Emory University and Grady Health System, the trial seeks to improve outcomes for patients with spontaneous ICH, currently lacking a proven surgical standard of care.